25O Phase I tolerability, persistence and pharmacodynamic (PD) profile of IV-administered next-generation adenoviral vectors supports clinical expansion in solid cancers

Saved in:
Bibliographic Details
Published in:ESMO open 2024-02, Vol.9, p.102353, Article 102353
Main Authors: Khalil, D., O'Cathail, S.M., Hawkins, M., Rosen, L.S., Camidge, D.R., Stacey, A., Thomas, M., Ji, R.R., Rosen, O., Naing, A.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2059-7029
2059-7029
DOI:10.1016/j.esmoop.2024.102353